ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: Cavenee Is President-elect of AACR; Coffey To Succeed Strong As President

April 11, 1997

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000